SAN DIEGO, Nov. 15, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem"), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that the underwriters of its previously announced initial public offering of common stock have exercised their option to purchase

SAN DIEGO, Nov. 13, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem"), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced the pricing of its initial public offering of 8,000,000 shares of common stock at a price of $15.00 per share.

SAN DIEGO, CA, October 07, 2013 Tandem Diabetes Care®, Inc. ("Tandem") a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of

SAN DIEGO, CA, September 30, 2013 Tandem Diabetes Care®, Inc. (“Tandem”) today announced  that its t:slim® Insulin Pump has been selected as a finalist in the Life Sciences – Medical Products category for the 2013 Most Innovative New Product Awards, sponsored by CONNECT.  The t:slim Pump is the

Tandem Diabetes Care Sponsors "Greatest Awards Show in Diabetes" SAN DIEGO, CA, August 13, 2013 Tandem Diabetes Care®, Inc. ("Tandem") announced today that it is the Presenting Sponsor of The Greatest Awards Show in Diabetes, presented by Insulindependence (IN), a nonprofit organization dedicated

SAN DIEGO, CA, June 20, 2013 Tandem Diabetes Care®, Inc. (“Tandem”) today announced that its t:slim® Insulin Pump was chosen as the Readers’ Choice for Most Innovative Product at the 2013 Medical Design Excellence Awards held in Philadelphia, PA on June 19, 2013.

SAN DIEGO, CA, April 02, 2013 Tandem Diabetes Care ® , Inc. (“Tandem”) today announced that the t:slim® Insulin Pump has been selected as a finalist in the 15th Annual Medical Design Excellence Awards competition. The t:slim Pump is the first touchscreen insulin pump for people with diabetes and

Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump SAN DIEGO, CA, February 26, 2013 Tandem Diabetes Care ® , Inc. (“Tandem”) today announced that its t:connect™ Diabetes Management Application, the web-based data management

Tandem Diabetes Care Names Lonnie Smith as Chairman of the Board SAN DIEGO, CA, February 20, 2013 Tandem Diabetes Care, Inc. (“Tandem”) today announced the appointment of Lonnie Smith as Chairman of its Board of Directors. Mr. Smith is Chairman of the Board and former chief executive officer of

Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical SAN DIEGO, CA, February 01, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today that it has acquired ownership from Smiths Medical ASD, Inc. of over 23 U.S.

Tandem Diabetes Care Announces Partnership with JDRF to Develop a Novel Dual-Chamber Infusion Pump SAN DIEGO, CA, January 08, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a

Tandem Diabetes Care and Dexcom Expand Development and Commercialization Agreement to Include Recently Approved G4™ PLATINUM CGM Sensor SAN DIEGO, CA, January 08, 2013 Tandem Diabetes Care, Inc. (“Tandem”) announced today that its Development and Commercialization Agreement with Dexcom, Inc., has

Tandem Diabetes Care Awarded CHAP Accreditation SAN DIEGO, CA, August 01, 2012 Community Health Accreditation Program, Inc., (CHAP) announced today that Tandem Diabetes Care, Inc. has been awarded CHAP accreditation under the CHAP Standards of Excellence.

PHILADELPHIA, PA, June 08, 2012 Tandem Diabetes Care™, Inc. (“Tandem”) announced today at the 72nd Scientific Sessions of the American Diabetes Association that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on

Future Generation CGM System to be Integrated with First Ever Touch Screen Insulin Pump

SAN DIEGO, CA, November 16, 2011 TandemDiabetes Care, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company clearance to market the t:slim™ Insulin Delivery System (t:slim). This new full-featured pump is the first-ever with a color touch screen, and is the

Tandem Diabetes Care Welcomes Bruce W. Bode, MD, FACE, to Clinical Advisory Board SAN DIEGO, CA, August 04, 2010 Tandem Diabetes Care, Inc., a privately-held company, today announced Bruce W. Bode, M.D., FACE, a known advocate for insulin pump therapy, has joined its clinical advisory board. Dr.

Founder of TCOYD, Steve Edelman, M.D. Joins Tandem Diabetes Care Advisory Board SAN DIEGO, CA, June 01, 2010 Tandem Diabetes Care, Inc., a privately-held company, today announced Steven V. Edelman, M.D., has joined the organization as a member of its clinical advisory board. Dr.

Tandem Diabetes Care Appoints Larry A Fox M.D to Clinical Advisory Board SAN DIEGO, CA, April 20, 2009 Tandem Diabetes Care, Inc., a privately-held company, is pleased to announce that Larry A. Fox, M.D., has joined the organization as a member of its clinical advisory board. Dr.

Tandem Diabetes Care Announces Plans for New Corporate Headquarters SAN DIEGO, CA, April 20, 2009 Tandem Diabetes Care, Inc., a privately held company, today announced plans to move and expand its corporate headquarters in San Diego. The Company has signed a lease agreement and is currently